Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV Naive. Randomized Clinical, Not Masked, Trial Comparing DRVr3TC, ABC3TC (Kivexa) RPV, or EVG COBI FTC TDF (Stribild) for 48 Weeks
Phase of Trial: Phase IV
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary) ; Darunavir; Lamivudine; Lamivudine/abacavir; Rilpivirine; Ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 04 Aug 2017 This trial has been completed in Spain, according to European Clinical Trials Database.
- 29 Jun 2016 Status changed from not yet recruiting to recruiting.
- 17 Jun 2015 New trial record